UK MHRA grants marketing authorisation to Biogen’s omaveloxolone to treat Friedreich’s ataxia: United Kingdom Friday, April 25, 2025, 12:00 Hrs [IST] The Medicines and Healthc ...

Hathway’s technology uses natural epigenetic processes to dial gene activity up or down, rather than rewriting the genetic ...

Biogen’s Skyclarys (omaveloxolone) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as the ...

In the first quarter, lower sales of BIIB's multiple sclerosis drugs are likely to have been offset by revenues from new ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Skyclarys (omaveloxolone), the first treatment ...

Biogen Netherlands has received marketing authorisation from the UK’s Medicines and Healthcare products Regulatory Agency ...

As with all products, we will keep its safety under close review. The Medicines and Healthcare products Regulatory Agency ...